Cardiology

Beta-blocker therapy cuts all-cause mortality in STEMI

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with reduced all-cause mortality, ...

Cardiology

Improved outcomes with greater use of transradial PCI

(HealthDay)—Greater change in hospital-level use of transradial percutaneous coronary intervention (TRI) is associated with improved periprocedural outcomes, according to a study published online June 4 in Circulation: ...

Diabetes

In STEMI, hyperglycemia tied to larger myocardial area-at-risk

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), hyperglycemia is associated with larger area-at-risk and infarct size, and the effect of exenatide treatment is independent of glucose levels, ...

page 35 from 40